CXCL10 and melanoma: Interestingly, immunokine profiling studies in the cerebrospinal fluid (CSF) of advanced melanoma patients showed that elevated levels of CXCL10, CCL17, and CCL4 may correlate with a more aggressive development of brain metastases [91].